# US 2012/0252101 A1 · Variants of bacillus sp. ts-23 alpha-amylase with altered properties

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252101 A1
- Document ID: US20120252101A1
- Status: Published application
- Kind: A1
- Application number: 13/410,486
- Filed: 2012-03-02
- Published: 2012-10-04
- Earliest claimed: 2008-02-04
- Assignees: Danisco US Inc.
- Inventors: Claudine Y. Chang; Clement Choy; Melodie Estabrook; Mansi Goyal; Thomas P. Graycar; Victoria E. Huang; Brian E. Jones; Marc Kolkman; Karsten M. Kragh; Chris Leeflang; Scott D. Power; Sandra W. Ramer; Andrew SHAW; Casper Vroemen; Walter Weyler
- Web page: https://patentgrep.com/patent/US20120252101A1

## CPC

- C12N 9/2417: {from microbiological source}
- A21D 8/042: {with enzymes}
- A23K 20/189: Enzymes
- A23K 50/75: for poultry
- A23L 29/06: {Enzymes}
- Y02E 50/10: Biofuels, e.g. bio-diesel
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A21D: TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS (preservation of flour or dough before baking A23B40/00; preservation of bakery products A23B45/00)
- A23K: FODDER
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

Variants of Bacillus sp. TS-23 strain alpha-amylases exhibit improved enzymatic performance, including increased themostability, reduced calcium dependence, increased washing/cleaning performance, and baking ability. Compositions comprising these variants are useful in methods of starch processing, starch liquefaction, fermatation, starch saccharification, cleaning, laundrying, textile desizing, baking, and biofilm removal.

## Claims

### Claim at position 1

-27. (canceled)

### Claim 28

An isolated nucleic acid encoding a variant of a parent Bacillus sp. TS-23 alpha-amylase, selected from the group consisting of:
(A) a variant of a parent Bacillus sp. TS-23 alpha-amylase, wherein the variant comprises an amino acid sequence with at least 90% amino acid sequence identity to SEQ ID NO: 2, wherein the variant has amylase activity, and wherein said variant comprises a truncation of the C-terminus, the modification S243Q, A, E, or D, and optionally any one or more of modifications (a) to (i), wherein each amino acid position corresponds to a position in SEQ ID NO: 1:
(a) R180 deletion or S181 deletion or R180 and S181 deletion;
(b) M201L;
(c) Q87 to E or R;
(d) N225 to E or R;
(e) N272 to E or R;
(f) N282 to E or R;
(g) T182 deletion;
(h) G183 deletion; or
(i) Q98R, M201L, S243Q, R309A, Q320R, Q359E, and K444E; and
(B) a variant of a parent Bacillus sp. TS-23 alpha-amylase, wherein said variant is encoded by a nucleic acid sequence that is complementary to a sequence that is capable of hybridizing under stringent conditions to an isolated nucleic acid encoding a variant of a parent Bacillus sp. TS-23 alpha-amylase, wherein the variant comprises an amino acid sequence with at least 90% amino acid sequence identity to SEQ ID NO: 2, wherein the variant has amylase activity, and wherein said variant comprises a truncation of the C-terminus, the modification S243Q, A, E, or D, and optionally any one or more of modifications (a) to (i), wherein each amino acid position corresponds to a position in SEQ ID NO: 1:
(a) R180 deletion or S181 deletion or R180 and S181 deletion;
(b) M201L;
(c) Q87 to E or R;
(d) N225 to E or R;
(e) N272 to E or R;
(f) N282 to E or R;
(g) T182 deletion;
(h) G183 deletion; or
(i) Q98R, M201L, S243Q, R309A, Q320R, Q359E, and K444E.

### Claim 29 (depends on 28)

The isolated nucleic acid of claim 28, wherein the variant of a parent Bacillus sp. TS-23 alpha-amylase comprises an amino acid sequence with at least 90% amino acid sequence identity to SEQ ID NO: 2, wherein the variant has amylase activity, and wherein said variant comprises a truncation of the C-terminus, the modification S243Q, A, E, or D, and, optionally any one or more of modifications (a) to (i), wherein each amino acid position corresponds to a position in SEQ ID NO: 1:
(a) R180 deletion or S181 deletion or R180 and S181 deletion;
(b) M201L;
(c) Q87 to E or R;
(d) N225 to E or R;
(e) N272 to E or R;
(f) N282 to E or R;
(g) T182 deletion;
(h) G183 deletion; or
(i) Q98R, M201L, S243Q, R309A, Q320R, Q359E, and K444E.

### Claim 30 (depends on 28)

An expression vector comprising the nucleic acid of claim 28 under control of a suitable promoter.

### Claim 31 (depends on 30)

An isolated host cell comprising the expression vector of claim 30.

### Claim 32 (depends on 31)

The isolated host cell of claim 31, wherein the isolated host cell is a bacterium or a fungus.

### Claim 33 (depends on 32)

The isolated host cell of claim 32, wherein the bacterium is a Gram positive bacterium selected from the group consisting of Bacillus subtilis, B. licheniformis, B. lentus, B. brevis, B. stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. coagulans, B. circulars, B. lautus, B. thuringiensis, Streptomyces lividans, and S. murinus; or a Gram negative bacterium, wherein said Gram negative bacterium is Escherichia coli or a Pseudomonas sp.
